ORCiD
David M. Ojcius: 0000-0003-1461-4495
Department
Biomedical Sciences
Document Type
Article
Publication Title
PLoS One
ISSN
1932-6203
Volume
8
Issue
7
DOI
10.1371/journal.pone.0070210
First Page
1
Last Page
12
Publication Date
7-25-2013
Abstract
We have previously reported that Porphyromonas gingivalis infection of gingival epithelial cells (GEC) requires an exogenous danger signal such as ATP to activate an inflammasome and caspase-1, thereby inducing secretion of interleukin (IL)-1β. Stimulation with extracellular ATP also stimulates production of reactive oxygen species (ROS) in GEC. However, the mechanism by which ROS is generated in response to ATP, and the role that different purinergic receptors may play in inflammasome activation, is still unclear. In this study, we revealed that the purinergic receptor P2X4 is assembled with the receptor P2X7 and its associated pore, pannexin-1. ATP induces ROS production through a complex consisting of the P2X4, P2X7, and pannexin-1. P2X−mediated ROS production can activate the NLRP3 inflammasome and caspase-1. Furthermore, separate depletion or inhibition of P2X4, P2X7, or pannexin-1 complex blocks IL-1β secretion in P. gingivalis-infected GEC following ATP treatment. However, activation via P2X4 alone induces ROS generation but not inflammasome activation. These results suggest that ROS is generated through stimulation of a P2X4/P2X7/pannexin-1 complex, and reveal an unexpected role for P2X4, which acts as a positive regulator of inflammasome activation during microbial infection.
Recommended Citation
Hung, S.,
Choi, C. H.,
Said-Sadier, N.,
Johnson, L.,
Atanasova, K. R.,
Sellami, H.,
Yilmaz, Ö.,
&
Ojcius, D. M.
(2013).
P2X4 assembles with P2X7 and pannexin-1 in gingival epithelial cells and modulates reactive oxygen species production and inflammasome activation.
PLoS One, 8(7), 1–12.
DOI: 10.1371/journal.pone.0070210
https://scholarlycommons.pacific.edu/dugoni-facarticles/74
Included in
Biochemistry Commons, Immunity Commons, Immunology of Infectious Disease Commons, Medical Immunology Commons
Comments
Article e70210